Spain Infection Control Market - Forecasts from 2020 to 2025
Spain infection control market is estimated to grow at a CAGR of 6.59% between 2019 and 2025. Spain is considered a world leader in organ transplants, hence on account of the maximum number of transplantation procedures conducted in the country, the market is expected to surge with high growth in the forecast period. Also, the presence of health centers and health clinics in Spain is further adding to increase market growth in the forecast period. The presence of good healthcare facilities for women and children is poised to drive the growth of the infection control market for these groups of population in the forecast period.
Moreover, the number of positive corona virus cases in the country is also increasing rapidly. Hence, it becomes necessary for the market to thrive in order to provide maximum protection to health workers and patients. Such epidemic and pandemic situations provide an opportunity for the market to grow at a high growth rate where it is projected to be at its peak during that time period.
A high organ transplantation rate is estimated to increase the growth of the infection control market in the forecast period.
Spain is considered as the world leader in organ donation, hence with a high rate of organ transplantation surgeries conducted every year, the demand for reducing surgical site infections during transplantation is propagating the market growth in the forecast period. According to the National Transplant Organization Statistics, in 2017, Spain attained an exceptional record of 46.9 donors per million population accounting for a total of 2183 donors. The number of donors is estimated to surge by around 30% in the last three years. According to the organization statistics, around 6 individuals donated organs every day, while 14 transplants were estimated to be performed per day. This has further led to the performing of 5,259 organ transplants, hence, surpassing a figure of around 5000 transplants for the first time, beating its own record. As per the data, the country has achieved a new record of 2,183 total number of donors (as mentioned earlier), and in the case of solid organ transplants, it was recorded as 5261 donors. There were 3269 kidney transplants performed in the same year, 1247 liver transplants were performed, 304 heart transplants were done, 363 lung transplants were performed, 70 pancreas transplants were conducted, and 8 intestinal transplants took place. Also, it was observed that the waiting list for all organs was reduced except for the pancreas.
The exclusive healthcare facilities for women will further augment the market growth in the forecast period.
The healthcare facilities for women in Spain are normally good, but in the urban environment the facilities are more readily available. The availability of gynecologists for pregnant women where most of the births occur in a hospital setting is projected to surge the market growth with the immense requirement for infection control at the time of childbirth. Also, with the provision of legal abortions in the country, the market is further estimated to grow at a significant pace in the forecast period. However, termination of a pregnancy is allowed under specific circumstances only, for example, in the case of a serious health risk to the life of the unborn or mother’s health.
Segmentation:
Moreover, the number of positive corona virus cases in the country is also increasing rapidly. Hence, it becomes necessary for the market to thrive in order to provide maximum protection to health workers and patients. Such epidemic and pandemic situations provide an opportunity for the market to grow at a high growth rate where it is projected to be at its peak during that time period.
A high organ transplantation rate is estimated to increase the growth of the infection control market in the forecast period.
Spain is considered as the world leader in organ donation, hence with a high rate of organ transplantation surgeries conducted every year, the demand for reducing surgical site infections during transplantation is propagating the market growth in the forecast period. According to the National Transplant Organization Statistics, in 2017, Spain attained an exceptional record of 46.9 donors per million population accounting for a total of 2183 donors. The number of donors is estimated to surge by around 30% in the last three years. According to the organization statistics, around 6 individuals donated organs every day, while 14 transplants were estimated to be performed per day. This has further led to the performing of 5,259 organ transplants, hence, surpassing a figure of around 5000 transplants for the first time, beating its own record. As per the data, the country has achieved a new record of 2,183 total number of donors (as mentioned earlier), and in the case of solid organ transplants, it was recorded as 5261 donors. There were 3269 kidney transplants performed in the same year, 1247 liver transplants were performed, 304 heart transplants were done, 363 lung transplants were performed, 70 pancreas transplants were conducted, and 8 intestinal transplants took place. Also, it was observed that the waiting list for all organs was reduced except for the pancreas.
The exclusive healthcare facilities for women will further augment the market growth in the forecast period.
The healthcare facilities for women in Spain are normally good, but in the urban environment the facilities are more readily available. The availability of gynecologists for pregnant women where most of the births occur in a hospital setting is projected to surge the market growth with the immense requirement for infection control at the time of childbirth. Also, with the provision of legal abortions in the country, the market is further estimated to grow at a significant pace in the forecast period. However, termination of a pregnancy is allowed under specific circumstances only, for example, in the case of a serious health risk to the life of the unborn or mother’s health.
Segmentation:
- By Product
- Disinfectant
- Sterilization
- Low temperature Sterilization
- Heat Sterilization
- Contract Sterilization
- By End User Industry
- Healthcare
- Food and Beverage
- Chemical
1. INTRODUCTION
1.1. Market Definition
1.2. Market Segmentation
2. RESEARCH METHODOLOGY
2.1. Research Data
2.2. Assumptions
3. EXECUTIVE SUMMARY
3.1. Research Highlights
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Market Opportunities
4.4. Porters Five Forces Analysis
4.4.1. Bargaining Power of Suppliers
4.4.2. Bargaining Power of Buyers
4.4.3. Threat of New Entrants
4.4.4. Threat of Substitutes
4.4.5. Competitive Rivalry in the Industry
4.5. Industry Value Chain Analysis
5. SPAIN INFECTION CONTROL MARKET ANALYSIS, BY PRODUCT
5.1. Introduction
5.2. Disinfectant
5.3. Sterilization
5.3.1. Low Temperature Sterilization
5.3.2. Heat Sterilization
5.3.3. Contract Sterilization
6. SPAIN INFECTION CONTROL MARKET ANALYSIS, BY END USER INDUSTRY
6.1. Introduction
6.2. Healthcare
6.3. Food and Beverage
6.4. Chemical
7. COMPETITIVE ENVIRONMENT AND ANALYSIS
7.1. Major Players and Strategy Analysis
7.2. Emerging Players and Market Lucrativeness
7.3. Mergers, Acquisitions, Agreements, and Collaborations
7.4. Vendor Competitiveness Matrix
8. COMPANY PROFILES
8.1. 3M
8.2. Medtronic
8.3. STERIS plc
8.4. B. Braun Melsungen AG
8.5. Getinge AB
8.6. List is not Exhaustive*
1.1. Market Definition
1.2. Market Segmentation
2. RESEARCH METHODOLOGY
2.1. Research Data
2.2. Assumptions
3. EXECUTIVE SUMMARY
3.1. Research Highlights
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Market Opportunities
4.4. Porters Five Forces Analysis
4.4.1. Bargaining Power of Suppliers
4.4.2. Bargaining Power of Buyers
4.4.3. Threat of New Entrants
4.4.4. Threat of Substitutes
4.4.5. Competitive Rivalry in the Industry
4.5. Industry Value Chain Analysis
5. SPAIN INFECTION CONTROL MARKET ANALYSIS, BY PRODUCT
5.1. Introduction
5.2. Disinfectant
5.3. Sterilization
5.3.1. Low Temperature Sterilization
5.3.2. Heat Sterilization
5.3.3. Contract Sterilization
6. SPAIN INFECTION CONTROL MARKET ANALYSIS, BY END USER INDUSTRY
6.1. Introduction
6.2. Healthcare
6.3. Food and Beverage
6.4. Chemical
7. COMPETITIVE ENVIRONMENT AND ANALYSIS
7.1. Major Players and Strategy Analysis
7.2. Emerging Players and Market Lucrativeness
7.3. Mergers, Acquisitions, Agreements, and Collaborations
7.4. Vendor Competitiveness Matrix
8. COMPANY PROFILES
8.1. 3M
8.2. Medtronic
8.3. STERIS plc
8.4. B. Braun Melsungen AG
8.5. Getinge AB
8.6. List is not Exhaustive*
